CoinShares Digital Securities Limited
CoinShares Digital Securities Limited: Index Securities – Amended Methodologies

7 November 2023

CoinShares Digital Securities Limited

Exchange Traded Products Programme for the issue of

CoinShares Digital Securities

LEI: 549300DR7967WVLR3P83

CoinShares Physical Top 10 Crypto Market Index Securities

CoinShares Physical Smart Contract Platform Index Securities

Jersey – 7 November 2023 – CoinShares Digital Securities Limited (the “Issuer”) announces that the Index Sponsor, Compass Financial Technologies (France), of the reference Index in respect of each of the CoinShares Physical Top 10 Crypto Market Index Securities and the CoinShares Physical Smart Contract Platform Index Securities, being the CoinShares-Compass Top 10 Crypto Market Index and the CoinShares-Compass Smart Contract Platform Index respectively, has published on its website at https://www.compass-ft.com an amended methodology for such Indices.  The amended methodology for each index states that with effect from 6 November 2023 the Index Committee has decided to add the following requirement in the list of Underlying Component Eligibility requirements:

To be considered as an Eligible Underlying Component, a cryptoasset linked to a CCRI Index needs, in addition to satisfying the other existing constraints, be supported by eligible custodians and market makers on relevant exchanges (each as defined by the Index Committee from time to time).

Terms used in this announcement and not otherwise defined bear the same meanings as where used in the base prospectus of the Issuer dated 3 March 2023.

For further information, please contact:

CoinShares Digital Securities Limited

2 Hill Street

St. Helier, Jersey,

JE24UA

Channel Islands

ir@coinshares.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.